miR‐150‐5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m⁶A Modification

MicroRNAs (miRNAs) are small regulatory molecules playing important roles in different physiological and pathological processes, but only several miRNAs were functionally characterized in Merkel cell carcinoma (MCC). We previously identified miR‐150‐5p as one of the differentially expressed miRNAs between MCC metastases and primary tumors. In the present study, we further investigated the functional role of miR‐150‐5p in MCC progression. Our results revealed that miR‐150‐5p suppresses the migratory and invasive properties of MCC cells. We identified RNA N6‐methyladenosine (m 6 A) demethylase FTO as a direct target of miR‐150‐5p . Functionally, we showed that FTO enhances proliferative, migratory and invasive properties of MCC cells, and rescued the antitumor effects induced by miR‐150‐5p . Mechanistically, we demonstrated that FTO stabilizes CTNNB1 transcripts via its m 6 A demethylation activity. Silencing the m 6 A reader YTHDF2 increased, while its overexpression decreased CTNNB1 mRNA and protein levels. Furthermore, the RNA immunoprecipitation assays demonstrated the interaction between CTNNB1 mRNA and YTHDF2. Together, these results suggest that FTO stabilizes CTNNB1 in an m 6 A‐dependent manner. In conclusion, our findings uncover the role of miR‐150‐5p and its target FTO in MCC progression, suggesting the potential of targeting FTO signaling for MCC therapy.